Archive for: MAR

Diagonal announces first pilot test at a stud with LAMPlify®

, , , ,
Diagonal Bio AB (publ) ("Diagonal Bio" or "the Company") announces a partnership with Gocksta Stud (Gocksta Stuteri), led by Anne-Sophie Thiam, to conduct a three-month pilot study, which begins immediately. This pilot test will evaluate LAMPlify’s…

Diagonal Bio AB Third Quarter Report (Q3 2024)

, , , , , , ,
“One of the most exciting developments is our effort into a new application of our technology LAMPlify®—this time in the domain of swine diseases.”Summary of Q3 report 20242024-07-01 — 2024-09-30 (July — September…

Diagonal Bio announces pilot test of LAMPlify® at Norwegian University of Life Sciences

, , , ,
Diagonal Bio AB (publ) ("Diagonal Bio" or "the Company") announces the commencement of a six-month pilot test of its point-of-care diagnostic platform, LAMPlify®, at the Norwegian University of Life Sciences (NMBU) in Ås. The pilot,…

Diagonal Bio announces successful external validation of LAMPlify® for viruses in pigs

, , , ,
Diagonal Bio AB (publ) (“Diagonal” or “the Company”) announces successful results of a recent pilot study conducted by the Centre for Diagnostics at DTU Health Technology. The study evaluated the performance of the LAMPlify®…

Hunneberga Horse Stable to conduct pilot test of LAMPlify®

, , , ,
Diagonal Bio AB (publ) ("Diagonal Bio" or "the Company") announces that Hunneberga Horse Stable (Hunneberga Hästgård) and Tomas Hammar, showjumping trainer and CEO at Hunneberga Horse Stable, has initiated a partnership with Diagonal…

Horse trainer Daniel Redén at StallZet will conduct a pilot with LAMPlify®

, , , ,
Diagonal Bio AB (publ) (“Diagonal Bio” or “the Company”) has partnered with StallZet and Daniel Redén, one of Sweden's leading horse trotting training facilities, to conduct a pilot test using LAMPlify® to…

Diagonal Bio announces successful external validation of LAMPlify® for respiratory viruses in horses

, , , ,
Diagonal Bio AB (publ) (“Diagonal Bio” and “the Company”) announces that its diagnostic tool, LAMPlify® has undergone a successful external validation in accordance with ISO 17025 standards. It is confirming that…

Diagonal Bio AB Second Quarter Report (Q2 2024)

, , , , , , ,
“In the second quarter of 2024, we have made advancements, particularly within the equine healthcare sector (horse veterinary clinics) where our connections and the interest in our Point-of-Care instrument continue to deepen.”Summary…

Diagonal Bio receives order from the Technical University of Denmark

, , , ,
Diagonal Bio AB (publ) (“Diagonal Bio” or “the Company”) has secured an order from the Technical University of Denmark (“DTU”) valued at just over 210,000 SEK for fish farms’ health project HURTIGFISK.…

Diagonal Bio announces strategic pilot study with Löberöds Hästklinik

, , , ,
Diagonal Bio AB (publ) (“Diagonal Bio” or “the Company”) is pleased to announce a significant new collaboration with Löberöds Hästklinik, led by renowned sporthorse veterinarian Lisa Lidbeck. The agreement,…